Long-term efficacy of vedolizumab for ulcerative colitis
EV Loftus Jr, JF Colombel, BG Feagan… - Journal of Crohn's …, 2017 - academic.oup.com
Abstract Background and Aims: The GEMINI long-term safety [LTS] study is a continuing
phase 3 trial investigating the safety and efficacy of vedolizumab, an α4β7 integrin …
phase 3 trial investigating the safety and efficacy of vedolizumab, an α4β7 integrin …
Long-term Efficacy of Vedolizumab for Ulcerative Colitis
EV Loftus, JF Colombel… - … of Crohn s & …, 2017 - researchinformation.amsterdamumc …
The GEMINI long-term safety [LTS] study is a continuing phase 3 trial investigating the safety
and efficacy of vedolizumab, an α4β7 integrin antagonist for ulcerative colitis [UC] and …
and efficacy of vedolizumab, an α4β7 integrin antagonist for ulcerative colitis [UC] and …
[PDF][PDF] Long-term Efficacy of Vedolizumab for Ulcerative Colitis
EV Loftus Jr, JF Colombel, BG Feagan… - Journal of Crohn's …, 2017 - assets-dam.takeda.com
Abstract Background and Aims: The GEMINI long-term safety [LTS] study is a continuing
phase 3 trial investigating the safety and efficacy of vedolizumab, an α4β7 integrin …
phase 3 trial investigating the safety and efficacy of vedolizumab, an α4β7 integrin …
Long-term Efficacy of Vedolizumab for Ulcerative Colitis
E Loftus, J Colombel, B Feagan, S Vermeire… - … OF CROHN'S AND …, 2017 - iris.hunimed.eu
Abstract Background and Aims: The GEMINI long-term safety [LTS] study is a continuing
phase 3 trial investigating the safety and efficacy of vedolizumab, an alpha (4) beta (7) …
phase 3 trial investigating the safety and efficacy of vedolizumab, an alpha (4) beta (7) …
Long-term Efficacy of Vedolizumab for Ulcerative Colitis
EV Loftus, JF Colombel, BG Feagan… - Journal of Crohn's …, 2017 - academic.oup.com
Methods: Patients from the C13004 and GEMINI 1 studies and a cohort of vedolizumab-
naïve patients received open-label vedolizumab every 4 weeks. Interim data were collected …
naïve patients received open-label vedolizumab every 4 weeks. Interim data were collected …
Long-term Efficacy of Vedolizumab for Ulcerative Colitis
E Loftus, J Colombel, B Feagan, S Vermeire… - … OF CROHN'S AND …, 2017 - iris.unisr.it
Abstract Background and Aims: The GEMINI long-term safety [LTS] study is a continuing
phase 3 trial investigating the safety and efficacy of vedolizumab, an alpha (4) beta (7) …
phase 3 trial investigating the safety and efficacy of vedolizumab, an alpha (4) beta (7) …
Long-term efficacy of vedolizumab for ulcerative colitis
EV Loftus, JF Colombel… - Journal of Crohn's …, 2017 - mayoclinic.elsevierpure.com
Abstract Background and Aims: The GEMINI long-term safety [LTS] study is a continuing
phase 3 trial investigating the safety and efficacy of vedolizumab, an α 4 ß 7 integrin …
phase 3 trial investigating the safety and efficacy of vedolizumab, an α 4 ß 7 integrin …
[引用][C] Long-term Efficacy of Vedolizumab for Ulcerative Colitis
EV Loftus, JF Colombel, BG Feagan… - Journal of Crohn's and …, 2016 - cir.nii.ac.jp
Long-term Efficacy of Vedolizumab for Ulcerative Colitis
EV Loftus Jr, JF Colombel… - Journal of Crohn's …, 2017 - pubmed.ncbi.nlm.nih.gov
Background and aims The GEMINI long-term safety [LTS] study is a continuing phase 3 trial
investigating the safety and efficacy of vedolizumab, an α4β7 integrin antagonist for …
investigating the safety and efficacy of vedolizumab, an α4β7 integrin antagonist for …
[PDF][PDF] Long-term Efficacy of Vedolizumab for Ulcerative Colitis
EV Loftus Jr, JF Colombel, BG Feagan… - Journal of Crohn's and …, 2017 - takeda.com
Abstract Background and Aims: The GEMINI long-term safety [LTS] study is a continuing
phase 3 trial investigating the safety and efficacy of vedolizumab, an α4β7 integrin …
phase 3 trial investigating the safety and efficacy of vedolizumab, an α4β7 integrin …